Add Company
Join Now

Atrogi Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Atrogi's estimated annual revenue is currently $5M per year.(i)
  • Atrogi's estimated revenue per employee is $251,250

Employee Data

  • Atrogi has 20 Employees.(i)
  • Atrogi grew their employee count by -5% last year.

Atrogi's People

NameTitleEmail/Phone
1
Head Chemistry and IPReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17.1M62-11%N/AN/A
#2
$99.7M49622%N/AN/A
#3
$22.9M114-67%N/AN/A
#4
$27.3M12814%N/AN/A
#5
$20.9M10428%N/AN/A
#6
$103.1M5134%N/AN/A
#7
$9.4M4618%N/AN/A
#8
$2.4M12-20%N/AN/A
#9
$28.1M14027%N/AN/A
#10
$5M20-5%N/AN/A
Add Company

What Is Atrogi?

Our vision is to market an state-of-the-art insulin-independent treatment to help T2D patients live a life free from diabetes symptoms and complications.

keywords:N/A

N/A

Total Funding

20

Number of Employees

$5M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Atrogi News

2022-03-22 - BioRestorative Therapies Announces Research Collaboration ...

Professor Bengtsson is also co-founder of Atrogi and Sigrid Therapeutics, two clinical stage companies. Atrogi is developing a novel small...

2022-03-22 - Atrogi inleder fas 1-studie av ATR-258 mot typ 2-diabetes efter ...

ATR-258 är en helt ny klass av läkemedelsmolekyler för behandling av T2D och genom sin unika verkningsmekanism uppnås inte bara positiva...

2022-03-22 - Atrogi receives first regulatory approval from German health ...

This promotes glucose uptake in skeletal muscle resulting in a reduction of blood glucose levels achieved without insulin. Atrogi believes ATR-...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.2M20-5%N/A
#2
$2.3M2067%N/A
#3
$4M20-13%N/A
#4
$1.8M20-9%N/A
#5
$2M2011%N/A